- Preparation and Development of Added Value Dossiers and Market Access Strategies for a vast array of therapeutic areas, from orphan to highly prevalent diseases (COVID-19, PFIC, Atopic Dermatitis, Antibiotics, Septic Shock, Polycythaemia Vera, COPD, Diabetes, so far).- Support to medicines reimbursement processes (hospital and outpatient), Legislation, Market Entry, and Public Affairs to pharma companies.- Building presentations for the training of pharma industry members on Market Access policies and Regulatory changes in Europe and health systems.- Support to annual review of prices processes.- Reviewing of a scientific journal (Revista Portuguesa de Farmacoterapia).

- Leader of the taskforce aiming for sustainability and carbon neutrality for the pharmacy group, which employes 70+ people;- Scientific Research: Author of an epidemiological study regarding the immune response of the vaccines against covid-19 with two more colleagues. The study was presented at the "I Jornadas de Farmácia Comunitária da Ordem dos Farmacêuticos 2021" ;- Temporary responsible for the pharmacy lab and pharmacotherapeutic follow-ups.

- Sterile Pharmaceutical Forms and Non-Sterile Production and Control- Drug Information and evaluation for the Pharmaceutical and Therapy Hospital Commission (CFT)• Clinical Pharmacy• Pharmacokinetics• Clinical Trials• Quality Management Systems• Audit of antibiotic use in surgery (PPCIRA)- Distribution Systems:• Classic, Custom and Single Unit Dose• Special Circuits: Narcotic Drugs, Psychotropic Drugs, Blood Products, Cytotoxic and Antiseptics- Supply Cycle and Inventory Management- Pharmacovigilance